Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Oxytrol, oxybutynin (Oxytrol patch)
print preview
bookmark
share with colleague
General Information
Company
Actavis Inc.
Description
Transdermal tertiary amine anticholinergic agent
Molecular Target
Muscarinic receptor
Mechanism of Action
Muscarinic receptor antagonist
Latest Stage of Development
Marketed
Indication
Incontinence
Partner
Merck & Co. Inc.
;
Paladin Labs Inc.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information